Collegium Pharmaceutical assumed with a Buy at H.C. Wainwright. H.C. Wainwright analyst Oren Livnat assumed coverage of Collegium Pharmaceutical with a Buy rating and $23 price target. The analyst sees an “undervalued growth story” given the “depressed opioid sentiment.”
https://thefly.com/landingPageNews.php?id=2902967
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.